Three and Six Months Ended June 30, 2025, Financial Statements and MD&A
Executive Summary
- Gabriel Resources reported Q2 2025 net loss of $1.2 M (down $2.0 M YoY) and YTD 2025 net loss of $4.8 M (down $0.3 M YoY), driven by lower corporate, general & administrative expenses.
- The company announced a proposed non‑brokered private placement of up to 34,305,000 units at $0.105 per unit for gross proceeds of up to US$2.625 M (≈ C$3.6 M).
- Ongoing ICSID arbitration annulment proceedings were detailed, including procedural calendar and recent developments that could affect the company’s financial condition.
Key Details
- Financial Performance – Q2 2025 vs Q2 2024
- Net loss: $1.2 M (down from $3.2 M).
- CGA expenses: $1.4 M (down $1.7 M).
- Foreign exchange gain: +$0.5 M.
-
Finance costs increase: +$0.1 M.
-
Financial Performance – YTD 2025 vs YTD 2024
- Net loss: $4.8 M (down from $5.1 M).
- CGA expenses: $4.2 M (down $1.2 M).
- Share‑based payments increase: +$0.8 M.
-
Finance costs increase: +$0.2 M.
-
Liquidity & Capital Resources
- Working capital deficiency: $17 M (slightly lower than $17.5 M at Dec 31 2024).
- Cash & cash equivalents: $0.7 M (down from $1.0 M).
- Cash used in operating activities YTD 2025: $3.8 M.
-
Cash provided by financing activities YTD 2025: $3.4 M (from prior private placement of 70,205,044 units).
-
Financing – Proposed Private Placement (Announced Aug 29 2025)
- Units offered: up to 34,305,000.
- Subscription price: $0.105 per unit (25% discount to prior close).
- Gross proceeds target: up to US$2.625 M (≈ C$3.6 M).
- Unit composition: 1 common share + 1 warrant (exercise price C$0.14, five‑year term).
-
Subject to TSXV approval.
-
ICSID Arbitration & Annulment Proceedings
- March 8 2024 – Tribunal rejected Gabriel’s claim; awarded ~US$10 M costs to Romania.
- Provisional stay of enforcement lifted April 25 2025; potential enforcement actions may affect assets.
- Procedural calendar set (Memorial Apr 3 2025, Counter‑Memorial Jul 7 2025, Reply Sep 1 2025, Rejoinder Nov 3 2025, Hearing Jan 22‑23 2026).
-
European Commission’s application to intervene denied Aug 25 2025.
-
Share Structure (as of release)
- Common shares outstanding: 239,781,984.
- Share purchase warrants outstanding: 114,152,000.
- Stock options outstanding: 1,931,051.
Notable Quotes
“The reduction in our CGA expenses reflects lower legal and arbitration costs, while the proposed financing will provide needed liquidity to advance our strategic objectives.” – Dragos Tanase, President & CEO
Materiality Assessment: Material – Neutral (the release contains material financial results, a significant financing announcement, and updates on litigation that could materially affect the company’s condition).